{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:06:20Z","timestamp":1769281580432,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Despite widespread use of combination antiretroviral therapy (cART), HIV-associated neurocognitive disorder (HAND) and HIV-associated myelopathy (HAM) are not showing significant reduction in there occurrence. The HAM is a progressive myelopathy that often occur synchronously with severe form of the HAND in patients\u2019 having advanced immunosuppression. However, co-existence of less severe form of the HAND and HAM in patient with relatively preserved CD4 cells is rarely reported clinical entity in post cART era.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report a 16-year old male, acquired HIV infection vertically, was on second line regimen because of virological failure since 3\u2009years. His current CD4 lymphocyte count is 835 cells\/uL with viral RNA level of 33,008 copies\/mL. Currently presented with progressive forgetfulness, gait imbalance, and a frequent staring episodes without loss of postural tone. Neurological examination was pertinent for cognitive dysfunction with score of 6 on International HIV Dementia Scale (motor speed\u2009=\u20093, psychomotor speed\u2009=\u20092, and memory recall\u2009=\u20091). Lower limbs power is 4<jats:sup>\u2212<\/jats:sup>\/5, increased deep tendon reflexes, and unsteady gait. Brain MRI revealed diffuse both cortical and white matter T2 and FLAIR hyperintense lesions. Thoracic MRI showed abnormal T2 signal prolongation spanning from mid thoracic cord to conus. Electroencephalography study showed severe generalized slowing with evidence of focal dysrhythmia in bilateral frontotemporal regions. Unremarkable serum vitamin B 12 level (286\u2009ng\/mL). Virological failure with the HAND, HAM and seizure was considered. Dolutegravir +3TC\u2009+\u2009ATV\/r regimen and valproate for seizure disorder was started. On 6 months follow up evaluation, he is clinically stable with significant improvement of his symptoms related to seizure disorders and modest improvement of his cognitive dysfunction, as he is now attending his school regularly. However, less improvement was observed reading his gait abnormality.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This case supports the current understanding regarding the persistent occurrence of HIV-associated neurocognitive disorder and HIV-associated myelopathy even decades after introduction of cART. Therefore, it\u2019s important to screen HIV+ patients for the HAND and HAM even if they have relatively preserved immunity. Because patient can be easily shifted to ART drugs with better CNS penetrating potential to achieve acceptable virological suppression level, to observe sound clinical improvement.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05297-9","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T09:03:02Z","timestamp":1596618182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-6030","authenticated-orcid":false,"given":"Biniyam Alemayehu","family":"Ayele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wondwossen","family":"Amogne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalise","family":"Gemechu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"5297_CR1","first-page":"4","volume":"53","author":"BC Ricardo","year":"2011","unstructured":"Ricardo BC. HIV associated dementia, a case report. Acta m\u00e9d Costarric. 2011;53:4.","journal-title":"Acta m\u00e9d Costarric"},{"key":"5297_CR2","first-page":"3","volume-title":"HIV-1 associated neurocognitive disorders in the HAART era in the Spectrum of Neuro-AIDS Disorders","author":"K Goodkin","year":"2009","unstructured":"Goodkin K, Aronow A, Baldwin G. HIV-1 associated neurocognitive disorders in the HAART era in the Spectrum of Neuro-AIDS Disorders. 1st ed. Washington DC: ASM Press; 2009. p. 3\u201327.","edition":"1"},{"issue":"14","key":"5297_CR3","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM198504043121402","volume":"312","author":"CK Petito","year":"1985","unstructured":"Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling sub-acute combined degeneration in patients with the acquired immunodeficiency syndrome. New England J Med. 1985;312(14):874\u20139.","journal-title":"New England J Med"},{"issue":"2","key":"5297_CR4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00588630","volume":"37","author":"CG Santosh","year":"1995","unstructured":"Santosh CG, Bell JE, Best JK. Spinal tract pathology in AIDS: postmortem MRI correlation with neuropathology. Neuroradiology. 1995;37(2):134\u20138.","journal-title":"Neuroradiology"},{"key":"5297_CR5","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/WNL.44.11.2159","volume":"44","author":"GJ Dal","year":"1994","unstructured":"Dal GJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study. Neurol. 1994;44:2159\u201364.","journal-title":"Neurol"},{"key":"5297_CR6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0344-0338(11)80540-6","volume":"186","author":"J Artigas","year":"1990","unstructured":"Artigas J, Grosse G, Niedobitek F. Vacuolar myelopathy in AIDS. A morphological analysis. Pathol Res Pract. 1990;186:228\u201337.","journal-title":"Pathol Res Pract"},{"key":"5297_CR7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.54.1.267","volume":"54","author":"R Staudinger","year":"2000","unstructured":"Staudinger R, Henry K. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology. 2000;54:267\u20138.","journal-title":"Neurology"},{"key":"5297_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s15010-001-0084-3","volume":"29","author":"WA Eyer-Silva","year":"2001","unstructured":"Eyer-Silva WA, Auto I, Pinto JF, Morais-de-S\u00e1 CA. Myelopathy in a previously asymptomatic HIV-1-infected patient. Infection. 2001;29:99\u2013102.","journal-title":"Infection"},{"key":"5297_CR9","unstructured":"William H., Neurology in Africa, University of Bergen, 2012, ISBN 978-82-7453-085-0."},{"issue":"12","key":"5297_CR10","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000038347.48137.67","volume":"59","author":"CH Hinkin","year":"2002","unstructured":"Hinkin CH, Castellon SA, Durvasula RS. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944\u201350.","journal-title":"Neurology"},{"issue":"5","key":"5297_CR11","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/ije\/dyu092","volume":"44","author":"JT Becker","year":"2015","unstructured":"Becker JT, Kingsley LA, Molsberry S. Cohort profile: recruitment cohorts in the neuropsychological sub study of the multicenter AIDS cohort study. Int J Epidemiol. 2015;44(5):1506\u201316. https:\/\/doi.org\/10.1093\/ije\/dyu092.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"5297_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3\u201316. https:\/\/doi.org\/10.1007\/s13365-010-0006-1.","journal-title":"J Neurovirol"},{"issue":"10","key":"5297_CR13","doi-asserted-by":"publisher","first-page":"e820","DOI":"10.1016\/j.ijid.2013.06.011","volume":"17","author":"AG Habib","year":"2013","unstructured":"Habib AG, Yakasai AM, Owolabi LF. Neurocognitive impairment in HIV-1infected adults in sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis. 2013;17(10):e820\u201331 https:\/\/doi.org\/10.1016\/j.ijid.2013.06.011.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"5297_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4314\/ejhs.v27i1.9","volume":"27","author":"B Tilahun","year":"2017","unstructured":"Tilahun B, Girmaw M, Ephrem Y. Prevalence of HIV Associated Neurocognitive Deficit among HIV Positive People in Ethiopia: A Cross Sectional Study at Ayder Referral Hospital. Ethiop J Health Sci. 2017;27(1):67\u201376. https:\/\/doi.org\/10.4314\/ejhs.v27i1.9.","journal-title":"Ethiop J Health Sci"},{"key":"5297_CR15","doi-asserted-by":"publisher","unstructured":"Getachew YY, Andualem MA, Moyeta BG, Gashaw GW. Prevalence of cognitive impairment and its predictors among HIV\/AIDS patients on antiretroviral therapy in Jimma University medical center, Southwest Ethiopia, Psychiatry Journal Volume, 2019:7 https:\/\/doi.org\/10.1155\/2019\/8306823.","DOI":"10.1155\/2019\/8306823"},{"key":"5297_CR16","doi-asserted-by":"publisher","unstructured":"Tsegaw M, Andargie G, Alem G, Tareke M. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in south Wollo, Ethiopia. J Psychiatr Res. 2016. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.10.016.","DOI":"10.1016\/j.jpsychires.2016.10.016"},{"issue":"3","key":"5297_CR17","doi-asserted-by":"publisher","first-page":"e0204636","DOI":"10.1371\/journal.pone.0204636","volume":"14","author":"AM Debalkie","year":"2019","unstructured":"Debalkie AM, Sorrie MB, Birhanu YW, Teshale MY. High prevalence of neurocognitive disorders observed among adult people living with HIV\/AIDS in Southern Ethiopia: A cross-sectional study. PLoS ONE. 2019;14(3):e0204636. https:\/\/doi.org\/10.1371\/journal.pone.0204636.","journal-title":"PLoS ONE"},{"issue":"1","key":"5297_CR18","first-page":"7","volume":"33","author":"G Zenebe","year":"1995","unstructured":"Zenebe G, Oli K, Redda TH. Paraplegia at the Tikur Anbessa Teaching Hospital: a seven year retrospective study of 164 cases. Ethiop Med J. 1995;33(1):7\u201313.","journal-title":"Ethiop Med J"},{"issue":"2","key":"5297_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1212\/WNL.57.2.348","volume":"57","author":"AI Bhigjee","year":"2001","unstructured":"Bhigjee AI, Madurai S, Bill PL, Patel V, Corr P, Naidoo MN. Spectrum of myelopathies in HIV seropositive South African patients. Neurology. 2001;57(2):348\u201351. https:\/\/doi.org\/10.1212\/WNL.57.2.348.","journal-title":"Neurology"},{"issue":"2","key":"5297_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/1596-3519.82062","volume":"10","author":"LF Owolabi","year":"2011","unstructured":"Owolabi LF, Ibrahim A, Samaila AA. Profile and outcome of non-traumatic paraplegia in Kano, northwestern Nigeria. Ann Afr Med. 2011;10(2):86\u201390. https:\/\/doi.org\/10.4103\/1596-3519.82062.","journal-title":"Ann Afr Med"},{"issue":"8","key":"5297_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/qjmed\/hcr038","volume":"104","author":"G Modi","year":"2011","unstructured":"Modi G, Ranchhod J, Hari K, Mochan A, Modi M. Non-traumatic myelopathy at the Chris Hani Baragwaneth Hospital, South Africa \u2013 the influence of HIV. QJM. 2011;104(8):697\u2013703. https:\/\/doi.org\/10.1093\/qjmed\/hcr038.","journal-title":"QJM"},{"issue":"1","key":"5297_CR22","first-page":"42","volume":"72","author":"G Zenebe","year":"1995","unstructured":"Zenebe G. Myelopathies in Ethiopia. East Afr Med J. 1995;72(1):42\u20135.","journal-title":"East Afr Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05297-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T23:16:36Z","timestamp":1628118996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05297-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5297"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05297-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors\u2019 institution does not require ethical approval for publication of a single case report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from patient\u2019s father and copy of the consent will be available from the corresponding author on reasonable request from the journal editor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"574"}}